Gastroenterology · Esophageal Neoplasms

Esophageal Cancer

USMLE2PANCE
7

Bets

The facts most likely to be tested

1

Adenocarcinoma is the most common esophageal malignancy in the United States and typically arises in the distal esophagus due to Barrett esophagus from chronic GERD.

Confidence:
2

Squamous cell carcinoma is the most common esophageal malignancy worldwide and is strongly associated with smoking and alcohol consumption.

Confidence:
3

Progressive dysphagia starting with solids and advancing to liquids, accompanied by unintentional weight loss, is the classic clinical presentation.

Confidence:
4

Endoscopy with biopsy is the gold standard diagnostic test for confirming the diagnosis of esophageal cancer.

Confidence:
5

Endoscopic ultrasound (EUS) is the most accurate modality for determining the depth of tumor invasion and assessing regional lymph node involvement for staging.

Confidence:
6

CT of the chest and abdomen or PET scan is required to evaluate for distant metastasis during the initial staging process.

Confidence:
7

Iron deficiency anemia in an older patient with a history of GERD or tobacco use should raise high suspicion for an occult esophageal malignancy.

Confidence:

Vignette unlocked

A 68-year-old male presents to the clinic with a 3-month history of progressive dysphagia to solids, now struggling to swallow soft foods. He reports a 15-lb unintentional weight loss over the same period. His medical history is significant for a 40-pack-year smoking history and long-standing heartburn treated with over-the-counter antacids. Physical examination reveals a thin, cachectic male with no palpable supraclavicular lymphadenopathy.

What is the most appropriate next step in the management of this patient?

+Reveal answer

Upper endoscopy with biopsy

The patient's presentation of progressive dysphagia and weight loss in the setting of significant risk factors is highly suggestive of esophageal cancer, necessitating direct visualization and tissue sampling via endoscopy.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Squamous cell: smoking/alcohol (upper 2/3). Adenocarcinoma: GERD/Barrett's (distal 1/3).

Clinical Manifestations

Progressive dysphagia (solids to liquids) and weight loss. Iron deficiency anemia.

Diagnosis

Upper endoscopy with biopsy is the gold standard. EUS for staging.

Treatment

Esophagectomy for localized disease. Neoadjuvant chemoradiation for locally advanced.

Prognosis

Poor overall survival; 5-year survival <20%. Metastasis to supraclavicular nodes.

Full handout

Epidemiology & Etiology

Squamous cell carcinoma (SCC) is globally most common, linked to tobacco and alcohol use. Adenocarcinoma is the most common type in the US, arising from Barrett's esophagus secondary to chronic GERD. Male gender and obesity are significant risk factors for adenocarcinoma.

Pertinent Anatomy

The esophagus lacks a serosa, allowing for rapid transmural invasion into adjacent structures. The upper 2/3 is squamous epithelium; the distal 1/3 is columnar epithelium, explaining the distinct histological distributions.

Pathophysiology

Chronic inflammation leads to metaplasia (Barrett's) or dysplasia. Genetic mutations, including p53 and HER2/neu overexpression, drive malignant transformation. Tumor growth leads to luminal narrowing, resulting in the classic clinical progression of dysphagia.

Clinical Manifestations

Patients present with progressive dysphagia (solids first, then liquids) and significant cachexia. Odynophagia, hoarseness (recurrent laryngeal nerve involvement), and hematemesis are red flags. Physical exam may reveal Virchow's node (left supraclavicular lymphadenopathy).

Diagnosis

Upper endoscopy with biopsy is the diagnostic gold standard. Endoscopic ultrasound (EUS) is the most accurate test for T-staging and nodal assessment. CT chest/abdomen is required for distant metastasis screening.

Treatment

Localized disease is treated with esophagectomy. Locally advanced disease requires neoadjuvant chemoradiation (e.g., 5-FU + cisplatin) prior to surgery. Palliative stenting is indicated for unresectable tumors causing obstruction.

Prognosis

Prognosis is generally poor due to late presentation. 5-year survival is typically <20%. Tracheoesophageal fistula is a devastating complication requiring urgent intervention.

Differential Diagnosis

Achalasia: dysphagia to solids AND liquids simultaneously

Esophageal stricture: history of chronic GERD or caustic ingestion

Esophageal web: Plummer-Vinson syndrome (iron deficiency + webs)

Zenker's diverticulum: halitosis and regurgitation of undigested food

Eosinophilic esophagitis: history of atopy and food impaction